Carol Routledge
Carol Routledge is a highly experienced professional in the pharmaceutical and healthcare industry with a strong background in research, clinical development, and neuroscience.
Currently, Carol serves as the Chief Medical & Scientific Officer at Small Pharma Ltd, where she plays a crucial role in overseeing medical and scientific aspects of the company.
Prior to her current position, she held the role of Director of Research at Alzheimer's Research UK, showcasing her dedication to advancing research in neurodegenerative diseases.
Throughout her career, Carol has held notable positions at various renowned organizations such as GlaxoSmithKline, BTG International, and SmithKline Beecham, where she contributed significantly to translational medicine, clinical pharmacology, and drug discovery.
With a wealth of experience as a leader in the healthcare sector, Carol has a proven track record of driving innovation and making substantial contributions to the field of neuroscience and drug development.
Her expertise ranges from early experimental research to clinical development, demonstrating a well-rounded skill set that is invaluable in the pharmaceutical industry.
Carol Routledge's extensive professional journey encompasses diverse roles that reflect her adaptability, knowledge, and commitment to advancing medical science and improving patient outcomes.
As a seasoned professional with a deep understanding of the complexities of drug development and clinical research, Carol continues to make significant contributions to the pharmaceutical and healthcare landscape.
